Business

Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026

VANCOUVER, B.C. & DALLAS, April 28, 2026--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will report its first quarter 2026 financial results and provide a business update on Thursday, May 14, 2026, at 4:30 p.m. ET, after market close.

articleAlpha Cognition Inc.April 28, 20264/company/alpha-cognition-inc/news/alpha-cognition-nasdaq-acog-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-thursday-may-14-2026
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026

About this update from Alpha Cognition Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1402,"height":504,"url":"https://media.zenfs.com/en/business-wire.com/e6edc13d16f0ead2269769a664634200"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rRj_T6Wkf.8VoyTw1zXYFg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTM0NQ--/https://media.zenfs.com/en/business-wire.com/e6edc13d16f0ead2269769a664634200","width":960,"height":345},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/TZ.ZzNmaw6RyXX6S7dKbZQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04NjI-/https://media.zenfs.com/en/business-wire.com/e6edc13d16f0ead2269769a664634200","width":1200,"height":431}},"lazy":false},{"type":"text","content":"Management to host conference call on Thursday, May 14, 2026 at 4:30pm ET","length":73,"tagName":"p"},{"type":"text","content":"VANCOUVER, B.C. & DALLAS, April 28, 2026--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will report its first quarter 2026 financial results and provide a business update on Thursday, May 14, 2026, at 4:30 p.m. ET, after market close.","length":364,"tagName":"p"},{"type":"text","content":"The company will issue a press release detailing its first quarter financial results and business highlights on that date. The financial results and accompanying materials will be available in the News section of the Alpha Cognition website at www.alphacognition.com/investors/news/.","length":283,"tagName":"p"},{"type":"text","content":"Following the release, management will host a conference call to review financial and operating results.","length":104,"tagName":"p"},{"type":"text","content":"Conference Call Information:","length":28,"tagName":"p"},{"type":"text","content":"To participate in the conference call, please use the dial-in information below:","length":80,"tagName":"p"},{"type":"text","content":"Participant Listening: 1-877-407-9039 or 1-201-689-8470","length":55,"tagName":"p"},{"type":"text","content":"or","length":2,"tagName":"p"},{"type":"text","content":"https://callme.viavid.com/viavid/?callme=true&passcode=13752398&h=true&info=company&r=true&B=6","length":114,"tagName":"p"},{"type":"text","content":"Participants can use guest dial-in #s above a...

More updates from Alpha Cognition Inc.

neurodegenerative diseasesThe companyAlpha Cognitionbiopharmaceutical companyAlpha Cognition Inc.conference callForward-looking Statements